Study to Investigate the Natriuretic Effects, Safety, Tolerability and Pharmacokinetics of BAY94-8862
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
Pharmacodynamics, pharmacokinetics, safety, and tolerability will be investigated in this
single dose study. In 5 treatment groups, different dosages of BAY94-8862 will be given in
healthy male subjects.